Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Effects of medicinal plants on Alzheimer's disease and memory deficits.

Akram M, Nawaz A.

Neural Regen Res. 2017 Apr;12(4):660-670. doi: 10.4103/1673-5374.205108. Review.

2.

Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.

Posner H, Curiel R, Edgar C, Hendrix S, Liu E, Loewenstein DA, Morrison G, Shinobu L, Wesnes K, Harvey PD.

Innov Clin Neurosci. 2017 Feb 1;14(1-2):22-29. eCollection 2017 Jan-Feb.

3.

Quantitative sodium MR imaging: A review of its evolving role in medicine.

Thulborn KR.

Neuroimage. 2016 Nov 24. pii: S1053-8119(16)30674-7. doi: 10.1016/j.neuroimage.2016.11.056. [Epub ahead of print]

PMID:
27890804
4.

Pharmacological management of anticholinergic delirium - theory, evidence and practice.

Dawson AH, Buckley NA.

Br J Clin Pharmacol. 2016 Mar;81(3):516-24. doi: 10.1111/bcp.12839. Epub 2015 Dec 29. Review.

5.

Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.

Ayaz M, Junaid M, Ullah F, Sadiq A, Khan MA, Ahmad W, Shah MR, Imran M, Ahmad S.

Lipids Health Dis. 2015 Nov 4;14:141. doi: 10.1186/s12944-015-0145-8.

6.
7.

Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects.

Yegla B, Parikh V.

Front Syst Neurosci. 2015 Jan 28;8:254. doi: 10.3389/fnsys.2014.00254. eCollection 2014. No abstract available.

8.

Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury.

Shin SS, Dixon CE.

J Neurotrauma. 2015 Oct 1;32(19):1429-40. doi: 10.1089/neu.2014.3445. Epub 2015 Jun 29. Review.

9.

Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L.

Ayaz M, Junaid M, Ahmed J, Ullah F, Sadiq A, Ahmad S, Imran M.

BMC Complement Altern Med. 2014 May 3;14:145. doi: 10.1186/1472-6882-14-145.

10.

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.

Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, Kivipelto M.

J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191. Review.

11.

Mild cognitive impairment in older adults.

Geda YE.

Curr Psychiatry Rep. 2012 Aug;14(4):320-7. doi: 10.1007/s11920-012-0291-x. Review.

12.

Alzheimer's disease.

Schachter AS, Davis KL.

Dialogues Clin Neurosci. 2000 Jun;2(2):91-100.

13.

Treatment of cognitive impairment in Alzheimer's disease.

Burns A.

Dialogues Clin Neurosci. 2003 Mar;5(1):35-43.

14.

Therapeutic approaches to age-associated neurocognitive disorders.

O'Hara R, Derouesné C, Fountoulakis KN, Yesavage JA.

Dialogues Clin Neurosci. 2001 Sep;3(3):191-213.

15.
16.

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Wallin AK, Wattmo C, Minthon L.

Neuropsychiatr Dis Treat. 2011;7:565-76. doi: 10.2147/NDT.S24196. Epub 2011 Sep 30.

17.

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.

Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S.

J Alzheimers Dis. 2011;26(3):495-505. doi: 10.3233/JAD-2011-110341.

18.

Alzheimer's disease and age-related memory decline (preclinical).

Terry AV Jr, Callahan PM, Hall B, Webster SJ.

Pharmacol Biochem Behav. 2011 Aug;99(2):190-210. doi: 10.1016/j.pbb.2011.02.002. Epub 2011 Feb 24. Review.

19.

Alzheimer disease.

Castellani RJ, Rolston RK, Smith MA.

Dis Mon. 2010 Sep;56(9):484-546. doi: 10.1016/j.disamonth.2010.06.001. Review. No abstract available.

20.

Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.

Lam B, Hollingdrake E, Kennedy JL, Black SE, Masellis M.

Hum Genomics. 2009 Dec;4(2):91-106. Review.

Supplemental Content

Support Center